Cardiovascular biomarker phenotype associated with immune checkpoint inhibitor therapy in patients with non-small cell lung cancer: an exploratory blood transcriptome study.
Journal: Frontiers in immunology
•
Abstract
Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.
Subjects & Keywords
How to Cite this Article
Ziemska-Legięcka J, Żeber-Lubecka N, Borucka M, et al. (2026). "Cardiovascular biomarker phenotype associated with immune checkpoint inhibitor therapy in patients with non-small cell lung cancer: an exploratory blood transcriptome study.". Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1972440